Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Declines By 70.3%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 3,083 shares, a decline of 70.3% from the July 30th total of 10,365 shares. Based on an average daily volume of 41,171 shares, the short-interest ratio is presently 0.1 days.

Alpha Tau Medical Price Performance

DRTSW traded down $0.21 during trading on Friday, hitting $3.79. 77,197 shares of the company traded hands, compared to its average volume of 62,468. The stock’s fifty day moving average is $3.31 and its 200 day moving average is $2.07. Alpha Tau Medical has a one year low of $0.20 and a one year high of $4.28.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.